Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06558149

The Effect of Nociception Level (NOL) Monitoring on Intraoperative Opioid Consumption in Hip Surgeries

Hip surgeries are one of the most painful surgical operations, and inadequate pain management increases postoperative morbidity and mortality.The incidence of chronic pain after hip surgery is quite high, at 11-40%.For this reason, hip surgeries are complex and specialized surgeries in terms of pain management.According to the surgical procedures pioneered by the European Society of Regional Anesthesia, Pericapsular nerve block (PENG) block is among the recommendations with a high level of evidence for hip surgery in the multimodal analgesia steps guide.In the literature, there are studies comparing the postoperative analgesic effectiveness of PENG block in hip surgeries, but the results are contradictory.In addition, intraoperative pain monitoring was not used in these studies, instead intraoperative analgesia management was provided according to hemodynamic parameters, which may not be objective.Opioid infusion is used in analgesia management during the intraoperative period.While not providing effective analgesia due to insufficient opioid use will have effects, excessive opioid use also has many side effects.Therefore, it would not be correct to administer the same dose of opioid infusion to every patient. As seen in the data in the literature and in daily practice, hemodynamic parameters (such as heart rate, blood pressure) are used for pain monitoring of the patient under general anesthesia, and these parameters may change depending on many other factors.Although some devices that aim to provide pain monitoring by evaluating the effects of pain on the sympathetic system are available on the market, their usage areas have remained limited since their reliability has not been fully demonstrated. Nociception level index (NoL) monitoring provides effective monitoring as it evaluates each patient separately using different parameters (heart rate, heart rate variability, photo-plethysmographic waveform amplitude, skin conductance level, number of skin conductance fluctuations and their time derivatives).While planning this study, İnvestigators aimed to use NoL monitoring in hip surgery, where postoperative pain management is quite challenging and important, as it provides objective and personalized pain management in patients under general anesthesia.When other studies in the literature are examined, the effects of regional techniques have been compared only in the postoperative period.Its effects in the intraoperative period have not been evaluated on a patient basis, and the opioid infusion rate has been adjusted with hemodynamic findings, which are affected by many parameters such as bleeding and drug use.In this study, İnvestigators aim to compare the effects of intraoperative pain monitoring and personalized analgesia treatment and the regional technique both in the intraoperative period and in the postoperative period.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ASA (American Society of Anesthesiologists) physical status classification I-IV patients who are planned to undergo hip surgery

Exclusion criteria

  • Allergies to study medications
  • serious renal, pulmonary, liver and endocrine diseases
  • have a history of chronic pain
  • Those with a history of bleeding diathesis
  • Those with increased intracranial pressure
  • Those with severe mitral and/or aortic stenosis
  • patients with psychiatric diseases and communication difficulties

Treatment and study plan

Those whose opioids were adjusted according to hemodynamic parameters

Procedure

Patient who will be adjusted according to hemodynamic parameter

Those whose opioids were adjusted according to NOL monitoring

Procedure

Patient who will be adjusted according to NOL monitoring

Primary outcomes

  1. Remifentanil consumption

    Time frame: Intraoperative

    Total amount of remifentanil used during the surgery (mg)

  2. NRS Scores

    Time frame: Postoperative 1st, 6th, 12th and 24th hours

    Numeric Rating Scale scores, between 0-10 (0= no pain, 10=worst pain imaginable)

  3. Morphine consumption

    Time frame: Postoperative 1st, 6th, 12th and 24th hours

    Amount of morphine in the postoperative period (mg)

Secondary outcomes

  1. Rescue analgesic

    Time frame: Postoperative 1st, 6th, 12th and 24th hours

    The use of rescue analgesic

  2. Nausea and vomiting

    Time frame: Postoperative 1st, 6th, 12th and 24th hours

    If the patient had nausea or vomiting, it will be recorded.

Study contacts

Contact information is provided by the study sponsor or research team.

Mehmet Bulut

CONTACT

[email protected]

+902623038248

Sponsors and collaborators

Lead sponsor

Kocaeli University

Other

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Aug 16, 2024
Registry last updated
Oct 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.